Clot Management Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Clot Management Devices Market is Segmented by Product (Embolectomy Balloon Catheter, Catheter Directed Thrombolysis Devices, Percutaneous Thrombectomy Devices, Inferior Vena Cava Filters, and Neurovascular Embolectomy Devices), End-User (Hospitals, Ambulatory Surgical Centers, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Value (in USD Million) for the Above Segments.

Clot Management Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Clot Management Devices Market Size

Clot Management Devices Market  Summary
Study Period 2019 - 2030
Market Size (2025) USD 1.96 Billion
Market Size (2030) USD 2.63 Billion
CAGR (2025 - 2030) 6.04 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Low

Major Players

Clot Management Devices Market  Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Clot Management Devices Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Clot Management Devices Market Analysis

The Clot Management Devices Market size is estimated at USD 1.96 billion in 2025, and is expected to reach USD 2.63 billion by 2030, at a CAGR of 6.04% during the forecast period (2025-2030).

The COVID-19 pandemic had a significant impact on the market studied. The risk of cardiovascular diseases increased during the pandemic and increased the risk of thrombosis (blood clotting) among the target patients. This increased the demand for the devices used for thrombosis management. According to the article "Cardiovascular Disease Management in COVID 19" published in April 2022, blood coagulation (clot) issues have been linked to COVID-19 infection globally.

In addition, another article, "Risks of Deep Vein Thrombosis, Pulmonary Embolism, and Bleeding After COVID-19: Nationwide Self-Controlled Cases Series and Matched Cohort Study," published in April 2022, stated that deep vein thrombosis increased during the pandemic, and it was higher during the initial phase of the pandemic in Sweden. Thus, for the management of thrombosis, the demand for clot management devices increased. This fuelled the studied market growth.

Factors such as the rise in cardiovascular diseases coupled with the increasing geriatric population, growing demand for minimally invasive surgeries, and technological advancements contribute to market growth. The rising geriatric population across the world is creating various disease burdens. This leads to increasing surgeries and blood clots among the target population.

The World Health Organization (WHO) estimates that by 2050, there will be 2.1 billion people worldwide who are 60 years of age or older, up from 1 billion in 2020. In addition, several sources and research show that the population aged 60 years or more is the foremost independent risk factor for deep vein thrombosis (when blood clot forms in one or more of the deep veins in the body). Thus, the increasing geriatric population coupled with the burden of thrombosis among them is expected to create demand for clot management devices, thereby driving the market growth over the analysis period.

Additionally, the global market for clot management devices has increased in recent years in product innovation, approval, and launches. For instance, in November 2021, Precision Medical Products (PMP) released the newest iteration of its Circul8 Pro device, a powerful and portable take-home deep vein thrombosis (DVT) prevention product. With 20-plus-hour battery life, the Circul8 Pro is one of the market's longest-lasting portables, battery-operated compression devices. Thus, such advances in the market are predicted to drive the studied market growth globally. Thus, the studied market is expanding with innovation and launches.

However, the stringent regulatory process and availability of alternative treatments are expected to restrain the market's growth.

Clot Management Devices Industry Overview

The clot management devices market is moderately competitive and consists of a few market players globally and regionally. Market players focus on product innovations, new product launches, and regional expansions to increase their market share. The key market players operating in the clot management devices market include Medtronic Plc, Boston Scientific Corporation, Edward Lifesciences, AngioDynamics, Inc., and LeMaitre Vascular, Inc., among others.

Clot Management Devices Market Leaders

  1. Medtronic Plc

  2. Boston Scientific Corporation

  3. Edward Lifesciences

  4. AngioDynamics, Inc.

  5. LeMaitre Vascular, Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Clot Management Devices Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Clot Management Devices Market News

  • April 2022: Penumbra, Inc., a global healthcare company focused on innovative therapies, announced that its Indigo Aspiration System with Lightning 7 and Lightning 12, designed for a single session blood clot removal in peripheral arterial and venous systems, including the treatment of pulmonary embolisms. The product secured the CE Mark and is now commercially available in Europe.
  • April 2022: Medtronic launched a registry for collecting real-world data associated with revascularisation devices in acute ischemic stroke (AIS) patients. The Prospective Registry for Assessment of Acute Ischemic Stroke Patients Treated with Neuro thrombectomy Devices in India (PRAAN) is an industry-first endeavor to create a post-market registry to assess clinical outcomes associated with the use of Medtronic market-released revascularisation devices in patients experiencing acute ischemic stroke. The duration of the registry will be approximately 28 months, and up to 200 subjects will be enrolled in it.

Clot Management Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Cardiovascular Diseases and Ageing Population
    • 4.2.2 Growing Demand for Minimally Invasive Surgeries and Advancements in Technologies
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Procedures
    • 4.3.2 Availability of Alternative Treatments
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value in USD million)

  • 5.1 By Product
    • 5.1.1 Embolectomy Balloon Catheter
    • 5.1.2 Catheter Directed Thrombolysis Devices
    • 5.1.3 Percutaneous Thrombectomy Devices
    • 5.1.4 Inferior Vena cava Filters
    • 5.1.5 Neurovascular Embolectomy Devices
  • 5.2 By End-User
    • 5.2.1 Hospitals
    • 5.2.2 Ambulatory Surgical Centers
    • 5.2.3 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Medtronic Plc
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 Edward Lifesciences
    • 6.1.4 Teleflex Incorporated
    • 6.1.5 Johnson & Johnson
    • 6.1.6 LeMaitre Vascular, Inc.
    • 6.1.7 Strub Medical GmbH & Co. KG
    • 6.1.8 AngioDynamics
    • 6.1.9 iVascular SLU
    • 6.1.10 Cook Group Incorporated
    • 6.1.11 Cardinal Health
    • 6.1.12 Stryker
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Clot Management Devices Industry Segmentation

As per the scope of the report, the formation of a thrombus in a blood vessel is known as thrombosis (blood clotting). This stops blood circulation in an artery or vein. Clot management devices help to remove or dissolve blood clots and restore blood circulation. 

The clot management devices market is segmented by by product (embolectomy balloon catheter, catheter directed thrombolysis devices, percutaneous thrombectomy devices, inferior vena cava filters, and neurovascular embolectomy devices), end-user (hospitals, ambulatory surgical centers and other end-users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. 

The report offers the value (in USD million) for the above segments.

By Product Embolectomy Balloon Catheter
Catheter Directed Thrombolysis Devices
Percutaneous Thrombectomy Devices
Inferior Vena cava Filters
Neurovascular Embolectomy Devices
By End-User Hospitals
Ambulatory Surgical Centers
Other End Users
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa GCC
South Africa
Rest of Middle-East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Clot Management Devices Market Research FAQs

How big is the Clot Management Devices Market?

The Clot Management Devices Market size is expected to reach USD 1.96 billion in 2025 and grow at a CAGR of 6.04% to reach USD 2.63 billion by 2030.

What is the current Clot Management Devices Market size?

In 2025, the Clot Management Devices Market size is expected to reach USD 1.96 billion.

Who are the key players in Clot Management Devices Market?

Medtronic Plc, Boston Scientific Corporation, Edward Lifesciences, AngioDynamics, Inc. and LeMaitre Vascular, Inc. are the major companies operating in the Clot Management Devices Market.

Which is the fastest growing region in Clot Management Devices Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Clot Management Devices Market?

In 2025, the North America accounts for the largest market share in Clot Management Devices Market.

What years does this Clot Management Devices Market cover, and what was the market size in 2024?

In 2024, the Clot Management Devices Market size was estimated at USD 1.84 billion. The report covers the Clot Management Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Clot Management Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Clot Management Devices Industry Report

Statistics for the 2025 Clot Management Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Clot Management Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.